Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Medical Facilities ( (TSE:DR) ) just unveiled an update.
Medical Facilities Corporation has announced a cash dividend of Cdn $0.09 per common share, payable on January 15, 2026, to shareholders of record as of December 31, 2025. This dividend is designated as an ‘eligible dividend’ under Canadian tax law. The announcement reflects the company’s ongoing commitment to providing value to its shareholders and highlights its stable financial position, which is supported by its portfolio of surgical facilities in the U.S.
The most recent analyst rating on (TSE:DR) stock is a Hold with a C$15.50 price target. To see the full list of analyst forecasts on Medical Facilities stock, see the TSE:DR Stock Forecast page.
Spark’s Take on TSE:DR Stock
According to Spark, TipRanks’ AI Analyst, TSE:DR is a Neutral.
The overall stock score of 63 reflects strong valuation metrics and profitability, offset by challenges in revenue growth and cash flow. Technical indicators are neutral, and the earnings call highlighted both achievements and significant challenges. The stock may be undervalued, but operational issues need addressing to improve future performance.
To see Spark’s full report on TSE:DR stock, click here.
More about Medical Facilities
Medical Facilities Corporation, in collaboration with physicians, owns a portfolio of high-quality surgical facilities in the United States. The company holds controlling interests in three specialty surgical hospitals in Arkansas, Oklahoma, and South Dakota, as well as an ambulatory surgery center in California. These facilities offer scheduled surgical, imaging, diagnostic, and other procedures, including primary and urgent care, with revenue generated from facility usage fees.
Average Trading Volume: 27,799
Technical Sentiment Signal: Buy
Current Market Cap: C$259.7M
For a thorough assessment of DR stock, go to TipRanks’ Stock Analysis page.

